ipilimumab,nivolumab,Oxaliplatin,Capecitabine,gimeracil,oteracil,tegafur,Pembrolizumab,Atezolizumab,5-Fluorouracil,Calciumfolinat,docetaxel,durvalumab
bms,Ono Pharmaceutical,nordic group,otsuka,Merck,Roche,Astrazeneca
[]
 yeah apparently pcr and survival do not significantly correlate
MD-PhD, MSc
Passionate Oncologist
Focus on Molecular Oncology 
Focus on Gastrointestinal Oncology